GraniteShares Advisors LLC Has $123,000 Holdings in Stryker Corporation $SYK

GraniteShares Advisors LLC cut its holdings in shares of Stryker Corporation (NYSE:SYK) by 89.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 351 shares of the medical technology company’s stock after selling 3,001 shares during the period. GraniteShares Advisors LLC’s holdings in Stryker were worth $123,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC increased its stake in shares of Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock valued at $1,643,000 after buying an additional 609 shares during the period. Schnieders Capital Management LLC. bought a new stake in shares of Stryker in the 2nd quarter valued at about $205,000. Edgestream Partners L.P. raised its holdings in Stryker by 70.5% in the second quarter. Edgestream Partners L.P. now owns 1,523 shares of the medical technology company’s stock worth $603,000 after purchasing an additional 630 shares during the period. Guggenheim Capital LLC raised its stake in Stryker by 2.5% during the 2nd quarter. Guggenheim Capital LLC now owns 6,180 shares of the medical technology company’s stock worth $2,445,000 after buying an additional 152 shares during the period. Finally, Marshall Wace LLP raised its position in shares of Stryker by 107.9% during the second quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company’s stock worth $2,255,000 after purchasing an additional 77,831 shares during the period. Institutional investors own 77.09% of the company’s stock.

Analysts Set New Price Targets

SYK has been the subject of a number of research analyst reports. William Blair reaffirmed an “outperform” rating on shares of Stryker in a research note on Thursday, March 5th. Needham & Company LLC boosted their target price on shares of Stryker from $448.00 to $454.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Truist Financial lowered their price target on Stryker from $400.00 to $392.00 and set a “hold” rating on the stock in a research report on Thursday, December 18th. Wall Street Zen upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Finally, Evercore set a $390.00 price target on Stryker in a research note on Monday, January 5th. Fourteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $427.50.

Stryker Stock Down 0.0%

Shares of SYK opened at $331.48 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.89 and a quick ratio of 1.21. Stryker Corporation has a one year low of $319.32 and a one year high of $404.87. The company has a market cap of $126.95 billion, a P/E ratio of 39.46, a P/E/G ratio of 1.94 and a beta of 0.92. The firm has a 50 day simple moving average of $357.10 and a two-hundred day simple moving average of $361.86.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, beating the consensus estimate of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The business had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. During the same period last year, the firm posted $4.01 earnings per share. Stryker’s revenue was up 11.4% compared to the same quarter last year. Research analysts forecast that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. Stryker’s dividend payout ratio (DPR) is 41.90%.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 250,000 shares of the business’s stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the sale, the director directly owned 2,457,331 shares in the company, valued at approximately $891,814,566.52. The trade was a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 5.90% of the company’s stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.